Literature DB >> 12470610

Acquisition of functional MHC class II/peptide complexes by T cells during thymic development and CNS-directed pathogenesis.

Mindi R Walker1, Mark D Mannie.   

Abstract

This study provides evidence that both rat and mouse thymic and splenic T cells express significant levels of MHC class II glycoproteins (MHCII) in vivo. Derivation of rat and mouse chimeras revealed that a major source of MHCII on thymic T cells was acquired from radioresistant host APC. Expression of MHC on thymic T cells appeared physiologically relevant because presentation of rat myelin basic protein (RMBP) by nonadherent, radiosensitive thymic T cells was associated with the adoptive transfer of tolerance. Mature MBP-specific effector T cells isolated from the CNS in both rat and mouse models of EAE also expressed significant levels of MHCII. Adoptive transfer of activated B10.PL MBP/I-A(u)-restricted TCR transgenic T cells into F1(C57BL/6 x B10.PL) mice revealed acquisition of allogeneic I-A(b) on encephalitogenic CNS-derived T cells. Overall, this study indicates that immature and mature T cells in rats and mice acquire functional MHCII in vivo during thymic development and pathogenic inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470610     DOI: 10.1016/s0008-8749(02)00577-4

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Authors:  Derrick P McCarthy; Maureen H Richards; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2012

2.  Experimental autoimmune encephalomyelitis in the mouse.

Authors:  Stephen D Miller; William J Karpus
Journal:  Curr Protoc Immunol       Date:  2007-05

Review 3.  Regulation of immune reactivity by intercellular transfer.

Authors:  Maxime Dhainaut; Muriel Moser
Journal:  Front Immunol       Date:  2014-03-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.